Hôpital Dupuytren

Limoges 87042

0 studies enrolling now · 3 studies all time

What they study most

Atrial Fibrillation, Leukemia, Myelomonocytic, Chronic, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Prevention of Stroke or Systemic Embolism

Studies at this site

• Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) — Stopped early
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs — Completed